Name: Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells (en Inglés)
Price: 630429.00 COP
Availability: InStock
Author: Heim, Sverre ; Mitelman, Felix
ISBN: 9781118795538

portada Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells (en Inglés)

Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells (en Inglés)

Formato

Libro Físico

Editorial

Wiley-Blackwell

Autor

Heim, Sverre ; Mitelman, Felix

Año

2015

Idioma

Inglés

N° páginas

648

Encuadernación

Tapa Dura

Dimensiones

25.4 x 17.3 x 3.0 cm

Peso

1.29 kg.

ISBN13

9781118795538

N° edición

0004

Categorías

Oncología

Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells (en Inglés)

Heim, Sverre ; Mitelman, Felix (Autor) · Wiley-Blackwell · Tapa Dura

Libro Nuevo Importado

Envío: 12 a 16 días háb.

$ 1.146.235$ 630.429

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 62 unidades

$ 630.429

¡Envío Gratis! Llega entre el 06 Jul y el 13 Jul a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells (en Inglés)"

The first three editions of this acclaimed book presented a much-needed conceptual synthesis of this rapidly moving field. Now, Cancer Cytogenetics, Fourth Edition, offers a comprehensive, expanded, and up-to-date review of recent dramatic advances in this area, incorporating a vast amount of new data from the latest basic and clinical investigations. New contributors reflecting broader international authorship and even greater expertise Greater emphasis throughout on the clinical importance and application of information about cytogenetic and molecular aberrations Includes a complete coverage of chromosome aberrations in cancer based on an assessment of the 60,000 neoplasms cytogenetically investigated to date Now produced in full color for enhanced clarity Covers how molecular genetic data (PCR-based and sequencing information) are collated with the cytogenetic data where pertinent Discusses how molecular cytogenetic data (based on studies using FISH, CGH, SNP, etc) are fused with karyotyping data to enable an as comprehensive understanding of cancer cytogenetics as is currently possible